COMPANY OVERVIEW

Compass Therapeutics has multiple antibody, antibody combination and bispecific programs advancing through preclinical development, targeting multiple pathways of significance for the immune system.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Autoimmune Disease

Inflammatory Disease

Oncology

---

WEBSITE

https://www.compasstherapeutics.com

---

CAREER WEBSITE

https://www.compasstherapeutics.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 23, 2020

Compass Therapeutics Completes Reverse Merger and Closes $60 Million Private Placement

Mar 30, 2020

Compass Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy and Safety of CTX-471, a Unique Fully Human Agonist of CD137

Feb 28, 2020

Compass Therapeutics to Present at the 40th Cowen Health Care Conference

Jan 6, 2020

Compass Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Dec 2, 2019

Compass Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference

For More Press Releases

---